Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTIBIOTIC THERAPY IN RESPIRATORY TRACT INFECTIONS (AIR)
2019-001873-10Phase 4Active
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jul 2019
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of amoxicillin, amoxicillin + clavulanate, ampicillin, erythromycin, clarithromycin and 6 more in community-acquired pneumonia (CAP), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Clinical cure at Day 15. Started Jul 2019; status: active.
02
Drugs
amoxicillinamoxicillin + clavulanateampicillinerythromycinclarithromycin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on 2019-001873-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001873-10.